Trade Olema Pharmaceuticals, Inc. - OLMA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.93 |
| Open | 5.9 |
| 1-Year Change | -61.11% |
| Day's Range | 5.77 - 6.18 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 4, 2025 | 6.13 | 0.32 | 5.51% | 5.81 | 6.20 | 5.77 |
| Feb 3, 2025 | 5.93 | 0.07 | 1.19% | 5.86 | 6.07 | 5.75 |
| Jan 31, 2025 | 6.06 | -0.17 | -2.73% | 6.23 | 6.55 | 5.97 |
| Jan 30, 2025 | 6.30 | 0.13 | 2.11% | 6.17 | 6.49 | 6.06 |
| Jan 29, 2025 | 6.17 | 0.42 | 7.30% | 5.75 | 6.25 | 5.74 |
| Jan 28, 2025 | 5.98 | -0.16 | -2.61% | 6.14 | 6.23 | 5.82 |
| Jan 27, 2025 | 6.11 | 0.34 | 5.89% | 5.77 | 6.38 | 5.77 |
| Jan 24, 2025 | 5.91 | 0.22 | 3.87% | 5.69 | 6.03 | 5.69 |
| Jan 23, 2025 | 5.81 | 0.35 | 6.41% | 5.46 | 5.82 | 5.43 |
| Jan 22, 2025 | 5.64 | 0.17 | 3.11% | 5.47 | 5.72 | 5.42 |
| Jan 21, 2025 | 5.48 | -0.15 | -2.66% | 5.63 | 5.89 | 5.45 |
| Jan 17, 2025 | 5.62 | 0.40 | 7.66% | 5.22 | 5.74 | 5.19 |
| Jan 16, 2025 | 5.23 | -0.22 | -4.04% | 5.45 | 5.77 | 5.17 |
| Jan 15, 2025 | 5.47 | 0.31 | 6.01% | 5.16 | 5.49 | 5.15 |
| Jan 14, 2025 | 5.09 | -0.17 | -3.23% | 5.26 | 5.26 | 4.75 |
| Jan 13, 2025 | 4.79 | -0.08 | -1.64% | 4.87 | 4.94 | 4.55 |
| Jan 10, 2025 | 4.99 | -0.49 | -8.94% | 5.48 | 5.52 | 4.89 |
| Jan 8, 2025 | 5.71 | 0.50 | 9.60% | 5.21 | 5.89 | 5.07 |
| Jan 7, 2025 | 5.20 | -0.17 | -3.17% | 5.37 | 5.49 | 5.02 |
| Jan 6, 2025 | 5.46 | -0.41 | -6.98% | 5.87 | 5.90 | 5.44 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Olema Pharmaceuticals, Inc. Company profile
About Olema Pharmaceuticals Inc
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of targeted therapies for women's cancers. Its lead product candidate, OP-1250, is an oral therapy with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). OP-1250 is an oral small molecule clinical-stage product candidate for the treatment of endocrine-driven cancers. It was designed based on a structural understanding of the ER. OP-1250, both as a monotherapy and in combination with inhibitors of cyclin-dependent kinase four and six (CDK4/6) demonstrated robust tumor shrinkage in several xenograft models, including a breast cancer brain metastasis model. It’s been ongoing Phase 1/2 clinical trial, and in Phase 1b combination with palbociclib, in patients with metastatic ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Olema Pharmaceuticals Inc revenues was not reported. Net loss applicable to common stockholders increased from $24M to $71.1M. Higher net loss reflects Research and development increase from $11.7M to $41.8M (expense), Stock-based Compensation in R&D increase from $2M to $9.3M (expense), General and administrative - Balancing increase from $6.7M to $13.8M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
780 Brannan Street
SAN FRANCISCO
CALIFORNIA 94103
US
News
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com